SEVERE IMMUNE THROMBOCYTOPENIA DURING FORMESTANE TREATMENT

Authors
ESPANOL I MUNIZDIAZ E ALONSO MC PUJOLMOIX N
Citation
I. Espanol et al., SEVERE IMMUNE THROMBOCYTOPENIA DURING FORMESTANE TREATMENT, Haematologica, 83(10), 1998, pp. 953-954
Citations number
10
Categorie Soggetti
Hematology
Journal title
Haematologica → ACNP
ISSN journal
03906078
Volume
83
Issue
10
Year of publication
1998
Pages
953 - 954
Database
ISI
SICI code
0390-6078(1998)83:10<953:SITDFT>2.0.ZU;2-M
Abstract
Formestane is a new aromatase inhibitor used as second-line endocrine treatment for postmenopausal women with advanced breast cancer. The mo st frequent side effects are local reactions. Here we report the devel opment of immune thrombocytopenia coinciding with administration of th is drug.